The International Renal Interest Society (IRIS) has recently updated their guidelines for diagnosing, staging and treating chronic kidney disease (CKD) to include the new kidney biomarker SDMA (symmetric dimethylarginine).This video will provide an overview of the IRIS CKD guidelines and how SDMA can be a useful adjunct for the early diagnosis of CKD as well as a guide for management of more advanced chronic kidney disease.